Boccatonda A, Del Cane L, Marola L, DArdes D, Lessiani G, Di Gregorio N
Life (Basel). 2024; 14(4).
PMID: 38672744
PMC: 11051088.
DOI: 10.3390/life14040473.
DeLeeuw P, Agbim U
Transl Gastroenterol Hepatol. 2022; 7:27.
PMID: 35892050
PMC: 9257532.
DOI: 10.21037/tgh-19-361.
Ogresta D, Mrzljak A, Cigrovski Berkovic M, Bilic-Curcic I, Stojsavljevic-Shapeski S, Virovic-Jukic L
J Clin Transl Hepatol. 2022; 10(2):339-355.
PMID: 35528987
PMC: 9039716.
DOI: 10.14218/JCTH.2021.00268.
Tripodi A, Lombardi R, Primignani M, La Mura V, Peyvandi F, Fracanzani A
Biomedicines. 2022; 10(2).
PMID: 35203457
PMC: 8869363.
DOI: 10.3390/biomedicines10020249.
McMurry H, Jou J, Shatzel J
Eur J Haematol. 2021; 107(4):383-392.
PMID: 34258797
PMC: 9009189.
DOI: 10.1111/ejh.13688.
Parenchymal Extinction Mimicking Hepatocellular Carcinoma in a Patient with Chronic Hepatitis B-Related Liver Cirrhosis.
Kang M, Choi J
Diagnostics (Basel). 2021; 11(7).
PMID: 34203262
PMC: 8306459.
DOI: 10.3390/diagnostics11071171.
Targeting von Willebrand factor in liver diseases: A novel therapeutic strategy?.
Groeneveld D, Poole L, Luyendyk J
J Thromb Haemost. 2021; 19(6):1390-1408.
PMID: 33774926
PMC: 8582603.
DOI: 10.1111/jth.15312.
Non-alcoholic fatty liver disease - a procoagulant condition?.
Virovic-Jukic L, Stojsavljevic-Shapeski S, Forgac J, Kukla M, Mikolasevic I
Croat Med J. 2021; 62(1):25-33.
PMID: 33660958
PMC: 7976878.
Liver fibrosis is driven by protease-activated receptor-1 expressed by hepatic stellate cells in experimental chronic liver injury.
Poole L, Pant A, Cline-Fedewa H, Williams K, Copple B, Palumbo J
Res Pract Thromb Haemost. 2020; 4(5):906-917.
PMID: 32685902
PMC: 7354391.
DOI: 10.1002/rth2.12403.
The Endothelium as a Driver of Liver Fibrosis and Regeneration.
Lafoz E, Ruart M, Anton A, Oncins A, Hernandez-Gea V
Cells. 2020; 9(4).
PMID: 32290100
PMC: 7226820.
DOI: 10.3390/cells9040929.
Direct Oral Anticoagulants in Patients with Liver Disease in the Era of Non-Alcoholic Fatty Liver Disease Global Epidemic: A Narrative Review.
Ballestri S, Capitelli M, Fontana M, Arioli D, Romagnoli E, Graziosi C
Adv Ther. 2020; 37(5):1910-1932.
PMID: 32285340
PMC: 7467481.
DOI: 10.1007/s12325-020-01307-z.
Portal vein thrombosis in cirrhosis: Why a well-known complication is still matter of debate.
Faccia M, Ainora M, Ponziani F, Riccardi L, Garcovich M, Gasbarrini A
World J Gastroenterol. 2019; 25(31):4437-4451.
PMID: 31496623
PMC: 6710174.
DOI: 10.3748/wjg.v25.i31.4437.
Increasing plasma ADAMTS13 activity is associated with HBeAg seroconversion in chronic hepatitis B patients during 5 years of entecavir treatment.
Guo R, Xie Y, Yang J, Lu H, Ye P, Jin L
Sci Rep. 2019; 9(1):5916.
PMID: 30976044
PMC: 6459868.
DOI: 10.1038/s41598-019-42421-5.
Anticoagulation in Cirrhosis and Portal Vein Thrombosis Is Safe and Improves Prognosis in Advanced Cirrhosis.
Ferreira C, Reis D, Cortez-Pinto H, Marinho R, Goncalves A, Palma S
Dig Dis Sci. 2019; 64(9):2671-2683.
PMID: 30852769
DOI: 10.1007/s10620-019-05572-z.
Chronic liver injury drives non-traditional intrahepatic fibrin(ogen) crosslinking via tissue transglutaminase.
Poole L, Pant A, Baker K, Kopec A, Cline-Fedewa H, Iismaa S
J Thromb Haemost. 2018; 17(1):113-125.
PMID: 30415489
PMC: 6322974.
DOI: 10.1111/jth.14330.
Crosslinked clots formed independently of factor XIII and without fibrinogen-to-fibrin conversion - is this a liver-specific phenomenon?.
Lisman T
J Thromb Haemost. 2018; 17(1):110-112.
PMID: 30412653
PMC: 7379741.
DOI: 10.1111/jth.14328.
Thromboelastography does not predict outcome in different etiologies of cirrhosis.
Hugenholtz G, Lisman T, Stravitz R
Res Pract Thromb Haemost. 2018; 1(2):275-285.
PMID: 30046697
PMC: 6058258.
DOI: 10.1002/rth2.12037.
Pathogenesis, prevention, and management of bleeding and thrombosis in patients with liver diseases.
Lisman T, Porte R
Res Pract Thromb Haemost. 2018; 1(2):150-161.
PMID: 30046685
PMC: 6058283.
DOI: 10.1002/rth2.12028.
Pleiotropic effects of statins in the diseases of the liver.
Janicko M, Drazilova S, Pella D, Fedacko J, Jarcuska P
World J Gastroenterol. 2016; 22(27):6201-13.
PMID: 27468210
PMC: 4945979.
DOI: 10.3748/wjg.v22.i27.6201.
Role of Fibrin(ogen) in Progression of Liver Disease: Guilt by Association?.
Kopec A, Luyendyk J
Semin Thromb Hemost. 2016; 42(4):397-407.
PMID: 27144445
PMC: 5338033.
DOI: 10.1055/s-0036-1579655.